论文信息 - Mitochondrial myopathy associated with anti-programmed cell death 1 therapy. - 字舞流文

Mitochondrial myopathy associated with anti-programmed cell death 1 therapy.

C. Robert | A. Slama | C. Adam | É. Routier | T. Ibrahim

[1] C. La Morgia,et al. Clinical syndromes associated with mtDNA mutations: where we stand after 30 years. , 2018, Essays in biochemistry.

[2] Matthieu Texier,et al. Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination , 2016, Nature Reviews Clinical Oncology.

[3] D. Ricard,et al. Pembrolizumab-induced necrotic myositis in a patient with metastatic melanoma. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[4] R. Frye,et al. Primary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and Treatment , 2016, Molecular Syndromology.

[5] Marni J. Falk,et al. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society , 2014, Genetics in Medicine.